Kidney Tubular Secretion Capacity and Risk of Cardiovascular Mortality in the General Population: The HUNT Study

Alexander L Bullen1,2, Ronit Katz3, Simon B Ascher4,5

  • 1Department of Medicine, Nephrology Section, Veterans Affairs San Diego Healthcare System, La Jolla, California.

Insights

Reduced kidney tubular secretion is linked to a higher risk of cardiovascular disease (CVD) mortality in the general population. This association persists even when accounting for kidney function and other risk factors.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Kidney tubular secretion is vital for clearing substances from the body.
  • Reduced tubular secretion is linked to cardiovascular disease (CVD) in advanced chronic kidney disease (CKD).
  • The association between tubular secretion and CVD risk in the general population is not well understood.

Purpose of the Study:

  • To investigate the relationship between kidney tubular secretion and CVD mortality in a general population.
  • To determine if impaired tubular secretion independently predicts CVD mortality.

Main Methods:

  • A case-cohort study design was used, sampling from the Trøndelag Health Study (HUNT-3).
  • A summary secretion score was created based on urine-to-plasma ratios of 12 endogenous solutes.
  • Weighted Cox proportional hazards models analyzed the association between the secretion score and CVD mortality.

Main Results:

  • Lower tubular secretion was associated with a 27% increased risk of CVD mortality per standard deviation decrease in the secretion score.
  • This association remained significant after adjusting for demographics, CVD risk factors, estimated glomerular filtration rate (eGFR), and albuminuria.
  • The findings were consistent across different demographic groups and individuals with or without reduced eGFR or albuminuria.

Conclusions:

  • Impaired kidney tubular secretion is an independent risk factor for CVD mortality in community-dwelling individuals.
  • The study highlights the importance of tubular function beyond just filtration (eGFR) in cardiovascular health.
  • These findings suggest potential therapeutic targets for reducing CVD risk by improving tubular secretion.
Abstract

Related Concept Videos

Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...